MyFinsight
Home
Blog
About
Contact
Download
Download image
License
$178,741K
Collaboration And Contracts
$204K
(-84.50%↓ Y/Y)
Non Cash Royalty
$181K
(-59.60%↓ Y/Y)
Revenues
$179,126K
(10054.54%↑ Y/Y)
Interest income
$815K
(-31.91%↓ Y/Y)
Income (loss) from
operations
$168,908K
(757.26%↑ Y/Y)
Total other income
$787K
(-32.91%↓ Y/Y)
Total operating
expenses
$10,218K
(-62.79%↓ Y/Y)
Interest expense
$17K
(-39.29%↓ Y/Y)
Foreign exchange (loss)
gain
-$11K
(-375.00%↓ Y/Y)
Net income (loss)
$169,695K
(791.90%↑ Y/Y)
General and
administrative
$5,889K
(0.98%↑ Y/Y)
Research and development
$4,120K
(-54.01%↓ Y/Y)
Change in fair value of
contingent consideration
$209K
(-30.10%↓ Y/Y)
Comprehensive income (loss)
$169,598K
(790.63%↑ Y/Y)
Unrealized loss on
available-for-sale securities
-$97K
(-212.90%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (ABUS)